Steve joined Isomerase in 2016 to support the next phase of commercialisation of the Company's proprietary technology platform. Steve was previously CEO of Zuvasyntha Ltd where he managed the growth and strategic refocusing of the company including securing major research collaborations with global industry partners, various rounds of seed investment and a merger with a US biotech company.
Prior to this Steve was R&D Director at TMO Renewables, where he was responsible for internal and external programs developing an industrial biotech platform for the production of renewable fuels and chemicals. Whilst at TMO, he helped the Company raise more than £40m in funding, and set up and participated in more than twenty grant-funded collaborations with UK and overseas universities.
Prior to TMO, Steve was Head of Fermentation at Cubist Pharmaceuticals and was responsible for the UK pilot plant and the fermentation activities at two manufacturing sites. Steve’s technical background is in microbial fermentation, process optimisation and scale-up. He has taken processes from concept to commercialisation and most notably was lead fermentation scientist for the process development and scale-up of the first-in-class lipopeptide antibiotic daptomycin (Cubicin™). He has more than 20 years’ industrial experience in the development of microbial processes for applications in the pharmaceutical and industrial biotechnology sectors and has authored many peer reviewed scientific papers, articles and patents. Steve is also founding Director of Inspire Biotech Ltd and a visiting lecturer and industrial fellow at the University of Bath.